Welcome to LookChem.com Sign In|Join Free
  • or
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-3-sulfooxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene is a complex steroid compound characterized by a cyclopenta[a]phenanthrene ring system. It features multiple methyl and hydroxyl groups, a sulfonic acid group attached to one of the hydroxyl moieties, and a 6-methylheptan-2-yl side chain at the 17th position. The intricate molecular structure of this chemical suggests potential for diverse biological activities and interactions with other molecules in biochemical processes.

1491-95-8

Post Buying Request

1491-95-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1491-95-8 Usage

Uses

Used in Pharmaceutical Industry:
(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-3-sulfooxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene is used as a pharmaceutical agent for its potential biological activities. The steroid nature of the compound and its functional groups may allow it to interact with various biological targets, making it a candidate for the development of new drugs.
Used in Biochemical Research:
In the field of biochemical research, (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl ]-3-sulfooxy-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a ]phenanthrene is utilized for studying the interactions between molecules and their effects on biological processes. Its complex structure and functional groups provide a basis for understanding how such molecules can influence cellular mechanisms and contribute to the advancement of scientific knowledge.

Check Digit Verification of cas no

The CAS Registry Mumber 1491-95-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,4,9 and 1 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1491-95:
(6*1)+(5*4)+(4*9)+(3*1)+(2*9)+(1*5)=88
88 % 10 = 8
So 1491-95-8 is a valid CAS Registry Number.

1491-95-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name [10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1491-95-8 SDS

1491-95-8Upstream product

1491-95-8Downstream Products

1491-95-8Relevant academic research and scientific papers

Desorption Electrospray Ionization Mass Spectrometry Assay for Label-Free Characterization of SULT2B1b Enzyme Kinetics

Cooks, R. Graham,Kulathunga, Samadhi C.,Mesecar, Andrew D.,Morato, Nicolás M.,Zhou, Qing

, (2022/02/17)

The sulfotransferase (SULT) 2B1b, which catalyzes the sulfonation of 3β-hydroxysteroids, has been identified as a potential target for prostate cancer treatment. However, a major limitation for SULT2B1b-targeted drug discovery is the lack of robust assays

USE OF OXYGENATED CHOLESTEROL SULFATES FOR TREATING AT LEAST ONE OF INSULIN RESISTANCE, DIABETES, AND PREDIABETES

-

Page/Page column 34; 35, (2022/01/05)

Aspects of the present disclosure include methods for treating at least one of insulin resistance, diabetes, and prediabetes, and, optionally, also non-alcoholic steatohepatitis (NASH). In practicing the subject methods, an effective amount of at least one compound selected from 25-hydroxycholesterol-3-sulfate (25HC3S), 25- hydroxycholesterol-disulfate (25HCDS), 27-hydroxycholesterol-3-sulfate (27HC3S), 27- hydroxycholesterol-disulfate (27HCDS), 24-hydroxycholesterol-3-sulfate (24HC3S), 24- hydroxycholesterol-disulfate (24HCDS), and 24,25-epoxycholesterol-3-sulfate, or salt thereof is administered to the subject.

Preparation method of medicinal sodium cholesteryl sulfate

-

Paragraph 0076-0083; 0107-0112, (2020/05/14)

The invention provides medicinal sodium cholesteryl sulfate and a preparation method thereof. By controlling the addition proportion of cholesterol, sulfamic acid and sodium hydroxide, the content ofsodium ions in the product is within the range of 4.5%-4.9%, it is guaranteed that the final reaction product is basically pure sodium cholesteryl sulfate and hardly contains cholesterol sulfate, anda qualified raw material is provided for safely and effectively applying sodium cholesteryl sulfate.

Direct analysis of sterols by derivatization matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and tandem mass spectrometry

Hailat, Iyad,Helleur, Robert J.

, p. 149 - 158 (2014/01/06)

RATIONALE Free sterols are neutral molecules that are difficult to analyze by MALDI or ESI and their molecular ions easily fragment. In order to increase their ionization efficiency and selectivity, sterols were derivatized by different reagents. METHODS Selected sterols were converted into their corresponding picolinyl esters, N-methylpyridyl ethers and sulphated esters. The derivatives were optimized for MALDI-TOFMS analysis through proper selection of the matrix. MALDI-TOF/TOF experiments were carried out to study the fragmentation pathways of the derivatives and their use in structural elucidation. Lipid extracts from mussels were used as test samples for MALDI analysis of sterols in biological samples also analyzed by GC/MS for comparison. RESULTS Sterol picolinyl esters were identified as sodiated adducts [M+Na] + and the signal significantly enhanced after addition of sodium acetate (20 mM). Sterol N-methylpyridyl ethers were easily detected as [M] + while sulphated sterols were best detected as [M-H]-. The ester bonds of picolinyl and sulphated esters easily cleaved in MS/MS resulting in diagnostic derivative fragments at m/z 146.03 and 96.89, respectively. Cleavage of the ether bond of N-methylpyridyl ethers gave a diagnostic fragment ion at m/z 110.04. Sterol profiles in mussels obtained by MALDI-TOFMS were in close agreement with those obtained by GC/MS. Two sterols (cholesterol and β-sitosterol) were selected for quantification as their sulphated and picolinyl esters. Calibration curves gave excellent correlation coefficients. CONCLUSIONS Suitable matrices for picolinyl esters are DHB and THAP, for N-methylpyridyl ethers THAP, and for sulphated esters p-nitroaniline and dithranol. Using cholesterol, the limits of detection (LODs) for sulphated esters were 0.2 μg/mL and for picolinyl esters, 1.5 μg/mL. N-Methylpyridyl ethers were found unsuitable for sterol quantitation. Copyright 2013 John Wiley & Sons, Ltd. Copyright

NOVEL VASCULAR LEAK INHIBITOR

-

Page/Page column 29-30, (2012/09/21)

The present disclosure relates to a novel vascular leakage inhibitor. The novel vascular leakage inhibitor of the present disclosure inhibits the apoptosis of vascular endothelial cells, inhibits the formation of actin stress fibers induced by VEGF, enhances the cortical actin ring structure, and improves the stability of the tight junctions (TJs) between vascular cells, thereby inhibiting vascular leakage. The vascular leakage inhibitor of the present disclosure has the activity of not only reducing vascular permeability but also recovering the integrity of damaged blood vessels. Accordingly, the vascular leakage inhibitor of the present disclosure can prevent or treat various diseases caused by vascular leakage. Since the vascular leakage inhibitor of the present disclosure is synthesized from commercially available or easily synthesizable cholesterols, it has remarkably superior feasibility of commercial synthesis.

ENZYMATIC SULFATION OF CHOLESTEROL BY RAT GASTRIC MUCOSA

Lin, Y. N.,Horowitz, M. I.

, p. 697 - 708 (2007/10/02)

A sulfotransferase which catalyzes transfer of the sulfate group from 3'-phosphoadenosine-5'phosphosulfate to cholesterol has been demonstrated in the rat gastric mucosa.The product of the reaction was characterized as cholesterol sulfate by two-dimensional thin-layer chromatography behavior, and gas-liquid chromatography of cholesterol after acid solvolysis.The bulk of enzyme activity was found in the cytosol fraction.Sulfation of cholesterol did not require added Mg+2, Mn+2, or Ca+2, and was unaffected by ethylenediaminetetraacetate.Triton X-100 moderatly enhanced the enzyme activity.A broad pH optimum from pH 6.0 - 9.0 was exhibited with a maximum at pH 7.0 - 7.5.The apparent Km for PAPS was 0.8 x 10-6M.The possible function of cholesterol sulfate in gastric mucosa is discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1491-95-8